Related Experiment Video

Updated: Jun 22, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc

C Elizabeth Caldon1, C Marcelo Sergio, Judith Schütte

  • 1Cancer Research Program, Garvan Institute of Medical Research, NSW, Australia.

Molecular and Cellular Biology
|July 1, 2009
PubMed

Insights

Estrogen promotes breast cancer cell proliferation by differentially regulating cyclin E1 and cyclin E2. Cyclin E2 levels increase via E2F1 and CHD8, while cyclin E1 activity is controlled by CDK inhibitors.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Research

Background:

  • Estrogen drives proliferation in breast cancer cells.
  • Cyclins E1 and E2, along with their partners Cdk2, regulate cell cycle progression.
  • The regulation of cyclin E1 and E2 during estrogen-induced proliferation is not fully understood.

Purpose of the Study:

  • To elucidate the distinct regulatory mechanisms of cyclin E1 and cyclin E2 during estrogen-induced breast cancer cell proliferation.
  • To investigate the roles of c-Myc, cyclin D1, E2F1, and CHD8 in the regulation of cyclin E1 and E2.

Main Methods:

  • ব্যবহার small interfering RNA (siRNA) to knock down specific genes (cyclin E1, cyclin E2, cyclin D1, CHD8).
  • Inducible expression systems to manipulate gene expression levels.
  • MCF-7 breast cancer cell line treated with estrogen and antiestrogens.
  • Analysis of protein levels and promoter activity.

Main Results:

  • Estrogen-induced proliferation involves distinct pathways for cyclin E1 and cyclin E2.
  • Cyclin E1-Cdk2 activity is regulated by p21(Waf1/Cip1) sequestration/downregulation, influenced by c-Myc and cyclin D1.
  • Cyclin E2 expression significantly increases via E2F1 and CHD8-mediated transcription, downstream of cyclin D1.
  • Knockdown of either cyclin E1 or E2 attenuated estrogen-mediated proliferation, highlighting their importance.

Conclusions:

  • Estrogen differentially regulates cyclin E1 and E2, impacting breast cancer cell proliferation.
  • Cyclin E2 is transcriptionally upregulated by estrogen through E2F1 and CHD8, downstream of cyclin D1.
  • Cyclin E1 and E2 are not always coordinately regulated, presenting distinct therapeutic targets.

More Related Videos

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...